3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
71
Colorectal Neoplasms
43
Rectal Neoplasms
41
Stomach Neoplasms
38
Triple Negative Breast Neoplasms
30
Neoplasm Metastasis
19
Esophageal Neoplasms
16
Colonic Neoplasms
16
Pancreatic Neoplasms
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Neoplasms
11
Nasopharyngeal Carcinoma
11
Adenocarcinoma
11
Biliary Tract Neoplasms
10
Adenocarcinoma Of Esophagus
9
Cholangiocarcinoma
8
Locally Advanced Rectal Cancer
6
Esophageal Squamous Cell Carcinoma
6
Brain Neoplasms
6
Anus Neoplasms
6
Recurrence
5
Gastrointestinal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neuroendocrine Tumors
4
HER2-positive Breast Cancer
4
Gallbladder Neoplasms
4
Colorectal Cancer Metastatic
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Pathologic Complete Response
3
Interventions
pembrolizumab
5
enfortumab vedotin
3
Gemcitabine
3
dodecyl maltoside
2
Sunitinib
2
Cisplatin
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
tucatinib
1
testosterone 17 beta-cypionate
1
temsirolimus
1
relatlimab
1
palbociclib
1
niraparib
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
cabozantinib
1
Valproic Acid
1
Urinary Diversion
1
Trastuzumab
1
Testosterone Propionate
1
Standard of Care
1
Sirolimus
1
Rivaroxaban
1
Ringer's acetate
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Capecitabine
×
1 year
×
Clear all
No trials found.